SERA PROGNOSTICS, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
SERA PROGNOSTICS, INC. (SERA) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$6.71 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-18
- SERA PROGNOSTICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$6.71M.
- SERA PROGNOSTICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$6.91M, a 190.87% decline from fiscal 2023.
- SERA PROGNOSTICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was $7.60M, a 18.06% decline from fiscal 2022.
- SERA PROGNOSTICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was $9.28M, a 26.21% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$6.71M 10-K · filed 2026-03-18 | |
| 2024-12-31 | -$6.91M 10-K · filed 2026-03-18 | $6.91M 10-K · filed 2025-03-19 |
| 2023-12-31 | $7.60M 10-K · filed 2025-03-19 | |
| 2022-12-31 | $9.28M 10-K · filed 2024-03-20 | |
| 2021-12-31 | $7.35M 10-K · filed 2023-03-22 | |
| 2020-12-31 | $4.17M 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |